| ESHRE Guideline: management of women with premature ovarian insufficiency | Human Reproduction | 2016 | 529 |
| The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis | Human Reproduction | 2016 | 526 |
| Criteria, prevalence, and phenotypes of polycystic ovary syndrome | Fertility and Sterility | 2016 | 397 |
| Uterine fibroid management: from the present to the future | Human Reproduction Update | 2016 | 291 |
| International Committee for Monitoring Assisted Reproductive Technologies world report: Assisted Reproductive Technology 2008, 2009 and 2010 | Human Reproduction | 2016 | 285 |
| Oocyte vitrification as an efficient option for elective fertility preservation | Fertility and Sterility | 2016 | 280 |
| Qualitative research methods: when to use them and how to judge them | Human Reproduction | 2016 | 273 |
| The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance | Human Reproduction Update | 2016 | 263 |
| Endometrial stem/progenitor cells: the first 10 years | Human Reproduction Update | 2016 | 255 |
| Assisted reproductive technology and the risk of pregnancy-related complications and adverse pregnancy outcomes in singleton pregnancies: a meta-analysis of cohort studies | Fertility and Sterility | 2016 | 213 |
| Ninety-five orthotopic transplantations in 74 women of ovarian tissue after cytotoxic treatment in a fertility preservation network: tissue activity, pregnancy and delivery rates | Human Reproduction | 2016 | 205 |
| Assisted reproductive technology in Europe, 2012: results generated from European registers by ESHRE | Human Reproduction | 2016 | 203 |
| Ovarian ageing: the role of mitochondria in oocytes and follicles | Human Reproduction Update | 2016 | 201 |
| Interactions between androgens, FSH, anti-Müllerian hormone and estradiol during folliculogenesis in the human normal and polycystic ovary | Human Reproduction Update | 2016 | 196 |
| Causes and consequences of oxidative stress in spermatozoa | Reproduction, Fertility and Development | 2016 | 196 |
| Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos? | Human Reproduction | 2016 | 196 |
| Prevalence of infertility and help seeking among 15 000 women and men | Human Reproduction | 2016 | 195 |
| The role of infection in miscarriage | Human Reproduction Update | 2016 | 191 |
| Introducing precise genetic modifications into human 3PN embryos by CRISPR/Cas-mediated genome editing | Journal of Assisted Reproduction and Genetics | 2016 | 182 |
| Cesarean scar pregnancy: a systematic review of treatment studies | Fertility and Sterility | 2016 | 179 |
| Autologous cell therapy with CD133+ bone marrow-derived stem cells for refractory Asherman's syndrome and endometrial atrophy: a pilot cohort study | Human Reproduction | 2016 | 177 |
| The Sperm Chromatin Structure Assay (SCSA(®)) and other sperm DNA fragmentation tests for evaluation of sperm nuclear DNA integrity as related to fertility | Animal Reproduction Science | 2016 | 176 |
| Hormone replacement therapy in young women with primary ovarian insufficiency and early menopause | Fertility and Sterility | 2016 | 174 |
| Extracellular vesicles: roles in gamete maturation, fertilization and embryo implantation | Human Reproduction Update | 2016 | 170 |
| Prevention and treatment of moderate and severe ovarian hyperstimulation syndrome: a guideline | Fertility and Sterility | 2016 | 170 |
